Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2025-12-24 @ 2:32 PM
NCT ID: NCT06904859
Eligibility Criteria: Inclusion Criteria: 1. Age 18-65 (≥ 18 years old, ≤ 65 years old) 2. gender is not limited 3. Acute myeloid leukemia patients 4. CR(remission phase, white blood cell count \> 2×10\^9/L after blood picture recovery) 5. After 3-4 courses of chemotherapy (the number of courses is not absolute) 6. Before the next chemotherapy Exclusion Criteria: 1. Transformed acute myeloid leukemia 2. Secondary acute myeloid leukemia 3. Post-transplantation acute myeloid leukemia 4. AML-M3 5. white blood cell count \<2×10\^9/L 6. More than 8 courses of chemotherapy 7. Combined with other immune-related diseases 8. Pregnancy
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT06904859
Study Brief:
Protocol Section: NCT06904859